Alembic Labs LLC

2 FDA products 2 active ingredients HUMAN PRESCRIPTION DRUG

Alembic Labs LLC is listed as the manufacturer on 2 FDA drug label records covering 2 distinct active ingredients predominantly human prescription drug products.

About Alembic Labs LLC

Alembic Labs LLC is named as the labeler on 2 FDA drug label records. Its catalogue spans 2 distinct active ingredients, led by GLYCOPYRROLATE, METRONIDAZOLE. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: metronidazole tablets, caused bacteroides, species including, fragilis group, vaginalis infection, liver abscess, adjunctive therapy, treatment asymptomatic. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
GLYCOPYRROLATE 1
METRONIDAZOLE 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — ORAL 2
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Alembic Labs LLC

Brand nameGenericTypeRoute
GLYCOPYRROLATE GLYCOPYRROLATE HUMAN PRESCRIPTION DRUG ORAL
Metronidazole METRONIDAZOLE HUMAN PRESCRIPTION DRUG ORAL

Frequently asked questions

How many FDA drug products does Alembic Labs LLC make?
2 FDA drug label records name Alembic Labs LLC as the manufacturer, covering 2 distinct active ingredients.

What active ingredients does Alembic Labs LLC produce?
The most frequent active ingredients in this portfolio are GLYCOPYRROLATE, METRONIDAZOLE.

Are Alembic Labs LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.